(Q46864257)

English

High variability of indinavir and nelfinavir pharmacokinetics in HIV-infected patients with a sustained virological response on highly active antiretroviral therapy

scientific article published in January 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16372824

High variability of indinavir and nelfinavir pharmacokinetics in HIV-infected patients with a sustained virological response on highly active antiretroviral therapy (English)

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16372824

0 references

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

Christine Katlama

8

object named as

Christine Katlama

0 references

Gilles Peytavin

6

object named as

Gilles Peytavin

1 reference

Europe PubMed Central

25 December 2017

Cécile Goujard

1

object named as

Cécile Goujard

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16372824

Anne-Marie Taburet

13

object named as

Anne-Marie Taburet

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16372824

Catherine Leport

9

object named as

Catherine Leport

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16372824

12

object named as

France Mentré

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16372824

author name string

Mayeule Legrand

2

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16372824

Xavière Panhard

3

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16372824

Bertrand Diquet

4

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16372824

Xavier Duval

5

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16372824

Isabelle Vincent

7

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16372824

Bénédicte Bonnet

10

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16372824

Dominique Salmon-Céron

11

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16372824

COPHAR1-ANRS 102 Study Group

14

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16372824

publication date

1 January 2005

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16372824

Clinical Pharmacokinetics

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16372824

44

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16372824

12

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16372824

1267-1278

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16372824

https://scigraph.springernature.com/pub.10.2165/00003088-200544120-00005

0 references

Interaction of anti-HIV protease inhibitors with the multidrug transporter P-glycoprotein (P-gp) in human cultured cells

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200544120-00005

21 January 2018

HIV lipodystrophy: risk factors, pathogenesis, diagnosis and management.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16372824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urological complaints in relation to indinavir plasma concentrations in HIV-infected patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/16372824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Population pharmacokinetics and pharmacodynamics of efavirenz, nelfinavir, and indinavir: Adult AIDS Clinical Trial Group Study 398.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16372824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Significance of P-glycoprotein for the pharmacology and clinical use of HIV protease inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/16372824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma levels of indinavir and nelfinavir at time of virologic response may have a different impact on the risk of further virologic failure in HIV-infected patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/16372824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Steady-state pharmacokinetics of twice-daily dosing of saquinavir plus ritonavir in HIV-1-infected individuals

1 reference

https://pubmed.ncbi.nlm.nih.gov/16372824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/16372824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of a twice-daily antiretroviral regimen containing 100 mg ritonavir/400 mg indinavir in HIV-infected patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/16372824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic drug monitoring in HIV infection: current status and future directions

1 reference

https://pubmed.ncbi.nlm.nih.gov/16372824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of P-glycoprotein in pharmacokinetics: clinical implications

1 reference

https://pubmed.ncbi.nlm.nih.gov/16372824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetic profile and tolerability of indinavir-ritonavir combinations in healthy volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/16372824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic drug monitoring: an aid to optimising response to antiretroviral drugs?

1 reference

https://pubmed.ncbi.nlm.nih.gov/16372824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Concentration-targeted therapy and the future of HIV management.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16372824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Virologic response to nelfinavir-based regimens: pharmacokinetics and drug resistance mutations (VIRAPHAR study).

1 reference

https://pubmed.ncbi.nlm.nih.gov/16372824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interactions among drugs for HIV and opportunistic infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/16372824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://pubmed.ncbi.nlm.nih.gov/16372824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High variability of plasma drug concentrations in dual protease inhibitor regimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/16372824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Significance of P-glycoprotein for the pharmacology and clinical use of HIV protease inhibitors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16372824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of intestinal P-glycoprotein on daily tacrolimus trough level in a living-donor small bowel recipient

1 reference

https://pubmed.ncbi.nlm.nih.gov/16372824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Competing drug-drug interactions among multidrug antiretroviral regimens used in the treatment of HIV- infected subjects: ACTG 884

1 reference

https://pubmed.ncbi.nlm.nih.gov/16372824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacological basis for concentration-controlled therapy with zidovudine, lamivudine, and indinavir

1 reference

https://pubmed.ncbi.nlm.nih.gov/16372824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High concentrations of nelfinavir as an independent risk factor for lipodystrophy in human immunodeficiency virus-infected patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/16372824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Concentration-controlled compared with conventional antiretroviral therapy for HIV infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/16372824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Principles and practice of HIV-protease inhibitor pharmacoenhancement

1 reference

https://pubmed.ncbi.nlm.nih.gov/16372824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determination of nelfinavir, a potent HIV protease inhibitor, and its active metabolite M8 in human plasma by high-performance liquid chromatography with photodiode-array detection

1 reference

https://pubmed.ncbi.nlm.nih.gov/16372824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Population pharmacokinetics of indinavir in patients infected with human immunodeficiency virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/16372824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Indinavir, efavirenz, and abacavir pharmacokinetics in human immunodeficiency virus-infected subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/16372824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nelfinavir plasma levels under twice-daily and three-times-daily regimens: high interpatient and low intrapatient variability.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16372824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systematic review and meta-analysis of evidence for increasing numbers of drugs in antiretroviral combination therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/16372824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intra-individual variability in lopinavir plasma trough concentrations supports therapeutic drug monitoring

1 reference

https://pubmed.ncbi.nlm.nih.gov/16372824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nelfinavir: an update on its use in HIV infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/16372824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factors affecting the clinical development of cytochrome p450 3A substrates

1 reference

https://pubmed.ncbi.nlm.nih.gov/16372824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Simultaneous high-performance liquid chromatographic determination of the antiretroviral agents amprenavir, nelfinavir, ritonavir, saquinavir, delavirdine and efavirenz in human plasma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16372824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic drug monitoring of nelfinavir and indinavir in treatment-naive HIV-1-infected individuals

1 reference

https://pubmed.ncbi.nlm.nih.gov/16372824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HIV-protease inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/16372824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factors affecting adherence to antiretroviral therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/16372824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16372824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Steady-state pharmacokinetics of amprenavir coadministered with ritonavir in human immunodeficiency virus type 1-infected patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/16372824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanisms of early virologic failure in antiretroviral-naive patients starting protease inhibitor-containing regimens: the APROVIR Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16372824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Importance of protease inhibitor plasma levels in HIV-infected patients treated with genotypic-guided therapy: pharmacological data from the Viradapt Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16372824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of indinavir/ritonavir (800/100 mg twice a day) combined with efavirenz in HIV-infected patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/16372824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adherence to protease inhibitor therapy and outcomes in patients with HIV infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/16372824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determination of indinavir in plasma by solid-phase extraction and column liquid chromatography.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16372824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sensitive and rapid method for the simultaneous quantification of the HIV-protease inhibitors indinavir, nelfinavir, ritonavir, and saquinavir in human plasma by reversed-phase liquid chromatography

1 reference

https://pubmed.ncbi.nlm.nih.gov/16372824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Dynamic of Adherence to Highly Active Antiretroviral Therapy: Results From the French National APROCO Cohort

1 reference

https://pubmed.ncbi.nlm.nih.gov/16372824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Variability in activity of hepatic CYP3A4 in patients infected with HIV.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16372824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determination of twelve antiretroviral agents in human plasma sample using reversed-phase high-performance liquid chromatography.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16372824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A retrospective, cohort-based survey of patients using twice-daily indinavir + ritonavir combinations: pharmacokinetics, safety, and efficacy

1 reference

https://pubmed.ncbi.nlm.nih.gov/16372824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Population pharmacokinetics and effects of efavirenz in patients with human immunodeficiency virus infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/16372824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Both baseline HIV-1 drug resistance and antiretroviral drug levels are associated with short-term virologic responses to salvage therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16372824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toxicity and drug exposure in a quadruple drug regimen in HIV-1 infected patients participating in the ADAM study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16372824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-dose ritonavir moderately enhances nelfinavir exposure

1 reference

https://pubmed.ncbi.nlm.nih.gov/16372824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-performance liquid chromatographic assay to determine the plasma levels of HIV-protease inhibitors (amprenavir, indinavir, nelfinavir, ritonavir and saquinavir) and the non-nucleoside reverse transcriptase inhibitor (nevirapine) after liquid-li

1 reference

https://pubmed.ncbi.nlm.nih.gov/16372824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00003088-200544120-00005

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16372824

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16372824

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46864257&oldid=2144528382"